Where do we stand on human diabetic nephropathy?

被引:2
|
作者
Cha, Dae Ryong [1 ]
机构
[1] Korea Univ, Ansan Hosp, Dept Internal Med, Ansan, Kyungki Do, South Korea
基金
新加坡国家研究基金会;
关键词
D O I
10.1016/j.krcp.2013.07.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:93 / 95
页数:3
相关论文
共 50 条
  • [41] WHERE DO WE STAND NOW
    GRIEF, NS
    NATURAL RESOURCES JOURNAL, 1993, 33 (02) : 507 - 521
  • [42] Pegasparaginase: where do we stand?
    Zeidan, Amer
    Wang, Eunice S.
    Wetzler, Meir
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (01) : 111 - 119
  • [43] Response: Where Do We Stand?
    Runnels, Curtis
    JOURNAL OF MEDITERRANEAN ARCHAEOLOGY, 2014, 27 (02): : 272 - 274
  • [44] WHERE DO WE STAND ON MANPOWER
    不详
    VETERINARY RECORD, 1995, 137 (01) : 1 - 1
  • [45] Xenotransplantation, where do we stand?
    Cozzi, E
    Ancona, E
    JOURNAL OF NEPHROLOGY, 2003, 16 : S16 - S21
  • [46] TRIBOLOGY - WHERE DO WE STAND
    CHARLES, T
    ENGINEERING MATERIALS AND DESIGN, 1970, 13 (01): : 47 - &
  • [47] Hyperfractionation: where do we stand?
    Stuschke, M
    Thames, H
    RADIOTHERAPY AND ONCOLOGY, 1998, 46 (02) : 131 - 133
  • [48] WHERE DO WE STAND NOW
    RABINOWITZ, S
    JUDAISM, 1977, 26 (03) : 274 - 278
  • [49] The GSEs: Where Do We Stand?
    Poole, William
    FEDERAL RESERVE BANK OF ST LOUIS REVIEW, 2013, 95 (06): : 601 - 611
  • [50] Toremifene:: where do we stand?
    Mäenpää, J
    Holli, K
    Pasanen, T
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S61 - S62